<DOC>
	<DOCNO>NCT02841774</DOCNO>
	<brief_summary>HILLCLIMBER randomize , control , open-label phase II trial moderate dose statin therapy ( pravastatin 40mg daily ) versus high-dose statin therapy ( rosuvastatin 20-40mg daily ) HIV-infected person take antiretroviral therapy ( ART ) coronary heart disease ( CHD ) .</brief_summary>
	<brief_title>High Intensity Lipid Lowering Following Acute Coronary Syndromes Persons Living With HIV</brief_title>
	<detailed_description>HILLCLIMBER randomize , control , open-label phase II trial moderate dose statin therapy versus high-dose statin therapy HIV-infected person take antiretroviral therapy ( ART ) coronary heart disease ( CHD ) . All subject initial 2-week run-in period pravastatin 40mg daily ( Week 0 2 ) . Subjects demonstrate significant toxicity week 2 randomize rosuvastatin 20mg ( high intensity dose group ) versus continue pravastatin 40mg daily ( moderate intensity group ) 12 week ( Weeks 2 14 ) . At week 6 , rosuvastatin arm demonstrate significant toxicity whose LDL-c &gt; 60mg/dl decrease less 25 % compare week 2 dos increase rosuvastatin 40mg .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>HIV1 infection HIV RNA low limit assay detection within 12 month study entry Documented coronary heart disease ( CHD ) : nonfatal MI , unrecognized MI , unstable angina pectoris , and/or stable angina pectoris , define American Heart Association Case Definitions Acute Coronary Heart Disease Epidemiology Clinical Research Studies Negative serum urine pregnancy test Men woman age 18 75 year age Serious illness AIDSrelated complication within 21 day screen require systemic treatment and/or hospitalization No coronary heart disease ( CHD ) . Not currently receive antiretroviral therapy take follow antiretroviral agent : atazanavir/ritonavir , lopinavir/ritonavir . History statin intolerance lead discontinuation , dose decrease , change less potent dose equivalent Statin absolute contraindication Current use atorvastatin 20mg daily great rosuvastatin 10mg daily great Chronic kidney disease stage 4 great ( include dialysis ) Systolic heart failure last documented LVEF &lt; 35 % Pregnant breastfeeding Laboratory value obtain within 45 day prior study entry : LDLc &lt; 80 mg/dl statin LDLc &lt; 60 mg/dl statin ALT &gt; 3 x Upper Limit Normal ( ULN ) AST &gt; 3 x ULN Creatinine kinase ( CK ) &gt; 3 x ULN ( calculate creatinine clearance ( CrCl ) &lt; 50 mL/min , estimate CockcroftGault equation ) Life expectancy &lt; 12 month Prior organ transplant Active malignancy Inflammatory muscle disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>